Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease

This publication has 18 references indexed in Scilit:

• Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate
  Arthritis & Rheumatism, 2004
• Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
  New England Journal of Medicine, 2003
• Magic bullets hit the target
  Nature, 2002
• Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
  Published by Elsevier ,2002
• ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
  Annual Review of Immunology, 1996
• Monoclonal anti‐TNFα Antibody as a Probe of Pathogenesis and Therapy of Rheumatoid Disease
  Immunological Reviews, 1995
• Construction and initial characterization of a mouse-human chimeric anti-TNF antibody
  Molecular Immunology, 1993
• Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine
  Clinical and Experimental Immunology, 1990
• The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection
  Cell, 1989
• Immunogenicity of recombinant DNA human insulin
  Diabetologia, 1983